Profusa, Inc.

Profusa, Inc. (PFSA) is a medical technology company focused on continuous physiological monitoring through injectable, tissue-integrated biosensor technology, operating within the medical devices and digital health sector. The company submitted an 8-K current report to the Securities and Exchange Commission on July 31, 2026, under accession number 0001213900-26-084064, disclosing a material corporate development in accordance with its ongoing public-company reporting obligations. Profusa's core platform centers on sensors engineered to track biomarkers such as oxygen and metabolic indicators directly within living tissue, targeting applications across clinical and consumer health monitoring. For sponsor details, full deal history, and SPAC analytics on PFSA, sign up for a free SpacDesk account.